Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Vinblastine × Other solid neoplasm × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4 Dermatologic 2 Other solid neoplasm 1

Conditions

Childhood Solid Tumor 1

Interventions

pembrolizumab 41 Injections 39 toripalimab 23 Nivolumab 21 Cisplatin 19 Pemetrexed 17 Cyclophosphamide 17 Carboplatin 16 Bevacizumab 15 Paclitaxel 14 fludarabine 11 tislelizumab 10 Gemcitabine 10 spartalizumab 9 Irinotecan 9 Ipilimumab 9 atezolizumab 8 Oxaliplatin 8 Leucovorin 8 Fluorouracil 8 Docetaxel 8 Capecitabine 6 Interleukin-2 5 Albumin-Bound Paclitaxel 5 trifluridine tipiracil drug combination 4 sintilimab 4 pazopanib 4 palbociclib 4 lenvatinib 4 Radiosurgery 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03585465 2026-03-18

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Active not recruiting

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡